Nutramax Laboratories, Inc. v. Twin Laboratories, Inc.

32 F. Supp. 2d 331, 1999 WL 16234
CourtDistrict Court, D. Maryland
DecidedFebruary 1, 1999
DocketCiv.A. B-97-787, B-97-1010, B-97-1712
StatusPublished
Cited by5 cases

This text of 32 F. Supp. 2d 331 (Nutramax Laboratories, Inc. v. Twin Laboratories, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Nutramax Laboratories, Inc. v. Twin Laboratories, Inc., 32 F. Supp. 2d 331, 1999 WL 16234 (D. Md. 1999).

Opinion

OPINION

WALTER E. BLACK, Senior District Judge.

Presently pending before the Court is a Motion to Strike Affidavits of William Faloon and for Sanctions Against Life Extension Foundation, Inc. filed on May 6, 1998, on behalf of plaintiff Nutramax Laboratories, Inc. (“Nutramax”). On March 18, 1997, Nutramax filed a patent infringement and patent violation suit against eight defendants in Nutramax Laboratories, Inc. v. Twin Laboratories, Inc. et al., Civil Action No. B-97-787. On April 4, 1997, Nutramax filed a complaint against three more defendants in Nutramax Laboratories, Inc. v. Life Extension Foundation, Inc., et al., Civil Action No. B-97-1010. On May 28, 1997, Nutramax filed a complaint against fourteen more defendants in Nutramax Laboratories, Inc. v. Foster & Smith, Inc., et al., Civil Action No. B-97-1712. The Court consolidated the three actions for discovery purposes on February 2,1998.

In response to a now withdrawn motion to correct the record filed by Life Extension Foundation, Inc. (“Life Extension”) on June 6, 1997, relating to service of process on another defendant, Prolongevity Ltd. (“Pro-longevity”), Nutramax moved for expedited discovery on the limited issues raised in Life Extension’s motion and on the relationship between Life Extension and Prolongevity through depositions of William Faloon, Vice President of Life Extension, and Katy Fischer, a receptionist at Life Extension. In particular, Nutramax requested permission to *333 depose these individuals, both of whom filed affidavits in support of Life Extension’s withdrawn motion to correct the record, to determine the relationship, if any, between Life Extension and Prolongevity. The Court granted plaintiffs request on January 28, 1998. Accordingly, the depositions were held on February 17, 1998, in Fort Lauderdale, Florida. At the depositions of Faloon in both his individual capacity and his capacity as corporate designee under Federal Rule of Civil Procedure 30(b)(6), Faloon repeatedly invoked the Fifth Amendment privilege against self incrimination in response to questions as to Life Extension’s relationship to other corporate entities including Prolongevity. As a result, Nutramax filed the pending motion to strike the affidavits 1 of Faloon and for sanctions against Life Extension.

I.

In its motion to strike the affidavits of Faloon, plaintiff argues that Faloon’s invocation of his Fifth Amendment rights was improper in both his individual and corporate capacities, designed to “frustrate Nutramax’s legitimate discovery efforts.” Plaintiff contends Faloon cannot offer affidavits in support of Life Extension’s position and then fail to answer legitimate questions regarding the assertions in those affidavits; therefore, the affidavits must be stricken. Plaintiff makes the same argument as to Faloon’s unsolicited speech at the end of his Rule 30(b)(6) deposition, and asks that it be stricken as well. Plaintiff also asserts that a corporate designee cannot invoke the protections of the Fifth Amendment because corporations do not enjoy the privilege. Accordingly, plaintiff moves for Rule 37 sanctions against Life Extension for improperly asserting the Fifth Amendment privilege. Plaintiff requests one of two proposed options for sanctions: (1) that the Court order Faloon to testify at further depositions as to those matters in which he asserted his privilege because he waived whatever privilege he had and that the Court order Life Extension to reimburse Nutramax for the costs of the February depositions in Florida; or in the alternative, (2) that the Court order that Nutramax be entitled to an adverse inference regarding the alter ego relationship between Life Extension and Prolongevity as a result of Falooris refusal to answer questions on that issue as well as order that Life Extension provide another Rule 30(b)(6) deponent who has been educated with the corporate information being sought.

Life Extension responded to plaintiffs motion with a motion for leave to file the affidavit of Guy A. Rasco 2 ex parte, which the Court granted subject to further order of the Court, and an opposition memorandum. Rasco’s affidavit sets forth past and anticipated criminal proceedings and investigations involving Faloon and Saul Kent, President of Life Extension, as the reasons behind Fa-loon’s Fifth Amendment assertions.

II.

In addressing plaintiffs pending motion, the Court must first determine whether Faloon properly invoked his Fifth Amendment privilege against self-incrimination at his depositions in Florida. It is well settled that the Fifth Amendment privilege may be asserted by a witness in any proceeding, civil or criminal. See Kastigar v. United States, 406 U.S. 441, 444-45, 92 S.Ct. 1653, 32 L.Ed.2d 212 (“[The Fifth Amendment privilege] can be asserted in any proceeding, civil or criminal ... and it protects against any disclosures which the witness reasonably believes could be used in a criminal prosecution or could lead to other evidence that might be so used.”), reh’g denied, 408 U.S. 931, 92 S.Ct. 2478, 33 L.Ed.2d 345 (1972). It may be invoked not only at trial but also at the pleading stage and in the course of discovery proceedings. North River Ins. Co., Inc. v. Stefanou, 831 F.2d 484, 486-87 (4th Cir. *334 1987), cert. denied, 486 U.S. 1007, 108 S.Ct. 1733, 100 L.Ed.2d 196 (1988).

In this ease, Faloon claims the privilege due to past and present threats of prosecution. The Court does not need to address the threats of any present or future prosecu-torial action to conclude that the November 1991 indictment, which has since been dismissed without prejudice, put Faloon in obvious jeopardy during the pendency of this case. See Hoffman v. United States, 341 U.S. 479, 486, 71 S.Ct. 814, 95 L.Ed. 1118 (1951) (“The privilege afforded not only extends to answers that would in themselves support a conviction under a federal criminal statute but likewise embraces those which would furnish a link in the chain of evidence needed to prosecute the claimant for a federal crime.”). Consequently, in his individual capacity, Faloon does have a Fifth Amendment privilege as a result of the 1991 indictment with respect to any testimony that might tend to incriminate him.

Nevertheless, the Court finds Faloon waived that privilege through the prior introduction of two affidavits 3 in which he swore to statements directly related to the matters raised in Life Extension’s withdrawn motion to correct the record and the relationship between Life Extension and Prolongevity. 4 See In re Edmond,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
32 F. Supp. 2d 331, 1999 WL 16234, Counsel Stack Legal Research, https://law.counselstack.com/opinion/nutramax-laboratories-inc-v-twin-laboratories-inc-mdd-1999.